Sunday, August 9, 2020
Home 2019 November

Monthly Archives: November 2019

Mitesco, Biotech Stock Review
Incubator

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic...

Editor / Curator -
Biotech News

Frontier Bio (FBIO) Bolstering it’s Warchest.

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Incubator

Is True Nature (TNTY) $0.04, Nearing a Breakout?

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Accelerator

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Editor / Curator -
AR THreats Report, Biotech Stock Reciew
Superbug News

AR Threats Report (CDC)

Editor / Curator -
biogen, biotech stock review
Biotech News

Biotech’s Turning Up…

Editor / Curator -
True Nature, Biotech Stock Review
Accelerator

True Nature | Mitesco (TNTY), Perking Up.

Editor / Curator -
Dyadic, Biotech Stock Review
Biotech News

Dyadic (DYAI) Highlights.

Editor / Curator -
Mustang Bio, Biotech Stock Review
Biotech News

Mustang Bio (MBIO) Highlights.

Editor / Curator -
Stand Down

Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell...

Editor / Curator -
12Page 1 of 2

Latest article

Does Co-Diagnostics (CODX) Have Ties to Offshore Boiler Rooms?

Superbug News Editor / Curator -
Hot Covid-19 test company has ties to offshore boiler rooms (SharesSleuth.com) AKA, you'd have to have your head examined...

Oganicell (BPSR), Lightning Strikes Twice, Up 327% – in a day..then another 60% this...

Superbug News Editor / Curator -
LIVE CHART Up on...
citius pharma, biotech stock review

Investors Bet $8 Million on Citius Pharma (CTXR) $1.10, Succeeding in FDA Trials!

2020 Watch List Editor / Curator -
Great headline, right? The actual headline was: Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.